Inhibition of C-C chemokine receptor-2 improves insulin resistance and hepatic steatosis in db/db mice

被引：0
|
作者：
Tamura, Yukinori
Sugimoto, Masayuki
Murayama, Toshinori
Kita, Toru
Yokode, Masayuki
Araikyoto, Hidenori
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A169 / A169
页数：1
相关论文
共 50 条
  • [21] Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2
    Hogaboam, CM
    Bone-Larson, CL
    Steinhauser, ML
    Matsukawa, A
    Gosling, J
    Boring, L
    Charo, IF
    Simpson, KJ
    Lukacs, NW
    Kunkel, SL
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04): : 1245 - 1252
  • [22] DGAT2 aso treatment improves hepatic steatosis, but not fibrosis in DB/DB mice fed methionine choline deficient diets
    Yamaguchi, Kanji
    Yang, Liu
    McCall, Shannon
    Huang, Jiawen
    Yu, Xing Xian
    Pandey, Sanjay K.
    Hanot, Sanjay
    Monia, Brett P.
    Li, Yin-Xiong
    Diehl, Anna Mae
    HEPATOLOGY, 2006, 44 (04) : 665A - 665A
  • [23] Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice
    Sleeman, MW
    Garcia, K
    Liu, R
    Murray, JD
    Malinova, L
    Moncrieffe, M
    Yancopoulos, GD
    Wiegand, SJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) : 14297 - 14302
  • [24] iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner
    H M Kim
    B R Lee
    E S Lee
    M H Kwon
    J H Huh
    B-E Kwon
    E-K Park
    S-Y Chang
    M-N Kweon
    P-H Kim
    H-J Ko
    C H Chung
    International Journal of Obesity, 2018, 42 : 270 - 279
  • [25] iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner
    Kim, H. M.
    Lee, B. R.
    Lee, E. S.
    Kwon, M. H.
    Huh, J. H.
    Kwon, B-E
    Park, E-K
    Chang, S-Y
    Kweon, M-N
    Kim, P-H
    Ko, H-J
    Chung, C. H.
    INTERNATIONAL JOURNAL OF OBESITY, 2018, 42 (02) : 270 - 279
  • [26] Ezetimibe Ameliorates Cardiovascular Complications and Hepatic Steatosis in Obese and Type 2 Diabetic db/db Mice
    Fukuda, Masaya
    Nakamura, Taishi
    Kataoka, Keiichiro
    Nako, Hisato
    Tokutomi, Yoshiko
    Dong, Yi-Fei
    Yasuda, Osamu
    Ogawa, Hisao
    Kim-Mitsuyama, Shokei
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (01): : 70 - 75
  • [27] Ginsenoside Rg5 relieves type 2 diabetes by improving hepatic insulin resistance in db/db mice
    Wei, Yange
    Yang, Haixia
    Zhu, Chenhui
    Deng, Jianjun
    Fan, Daidi
    JOURNAL OF FUNCTIONAL FOODS, 2020, 71
  • [28] Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice
    Zhang, Xiao-dong
    Yan, Jian-wei
    Yan, Gui-rui
    Sun, Xiao-yun
    Ji, Jun
    Li, Yi-ming
    Hu, You-hong
    Wang, He-yao
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (11) : 1470 - 1477
  • [29] C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis
    Obstfeld, Amrom E.
    Sugaru, Eiji
    Thearle, Marie
    Francisco, Anne-Marie
    Gayet, Constance
    Ginsberg, Henry N.
    Ables, Eleanore V.
    Ferrante, Anthony W., Jr.
    DIABETES, 2010, 59 (04) : 916 - 925
  • [30] Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice
    Xiao-dong Zhang
    Jian-wei Yan
    Gui-rui Yan
    Xiao-yun Sun
    Jun Ji
    Yi-ming Li
    You-hong Hu
    He-yao Wang
    Acta Pharmacologica Sinica, 2010, 31 : 1470 - 1477
12345